Neuropathology of Parkinson disease

Cited by (623)

Items 501–600 of 623

1. Exercise prescription for Parkinson's disease patients: Dealing with cardiovascular autonomic dysfunction
   Hélcio Kanegusuku, Marília de Almeida Correia, Gabriel Grizzo Cucato, Raphael Mendes Ritti‐Dias · 2021 · Revista Portuguesa de Cardiologia
2. Neurodegenerative Erkrankungen
   Anne‐Sophie Biesalski, Jos Steffen Becktepe, Thorsten Bartsch, Christiana Franke · 2018 · Springer eBooks
3. One Autopsy Proved Neocortical Lewy Body Disease Without the Involvement of the Olfactory Bulb and Brainstem
   Eun Joo Chung, Hwa Jin Cho, Dae Young Hur, Yeong Seok Kim, Kyung‐Hwa Lee, Sang Jin Kim · 2022 · Journal of Korean Medical Science
4. Association between Serum Alpha-Synuclein Levels and Parkinson's Disease Stage
   Yuliarni Syafrita, Restu Susanti · 2022 · Global Medical & Health Communication (GMHC)
5. Optimal Robust Control For Tremor Suppression in Parkinson’s Disease
   Mobin Saeedi, Jafar Zarei, Hoda Balouchi, Roozbeh Razavi‐Far, Mehrdad Saif · 2022 · Conference proceedings/Conference proceedings - IEEE International Conference on Systems, Man, and Cybernetics
6. The role of magnetic resonance imaging in the diff erential diagnosis of Parkinson’s disease
   Alexey A. Tappakhov, Tatiana E. Popova · 2023 · Russian neurological Journal
7. Erythropoietin as a Modulator of Pathology in a Toxicant Mouse Model of Parkinson’s Disease
   Ashley Thompson · 2019
8. Adapted functional training versus Mat Pilates in motor and non-motor symptoms of individuals with Parkinson's disease: study protocol for a randomized controlled clinical trial Functional training versus Mat Pilates in Parkinson's disease
   Jéssica Moratelli, Kettlyn Hames Alexandre, Leonessa Boing, Melissa de Carvalho Souza Vieira, Adriana Coutinho de Azevedo Guimarães · 2021 · Research Square
9. Network Based Identification of Holistic Drug Target for Parkinson Disease and Deep Learning assisted Drug Repurposing
   Ahsan Raza, Muhammad Muddassar · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
10. Editorial: Highlights in Alzheimer's and Parkinson's disease
    Mariagiovanna Cantone, Leonardo Sacco · 2023 · Frontiers in Human Neuroscience
11. Defining The Potential Of Gene Therapy With Bone Morphogenetic Proteins As A Novel Therapeutic Approach In Parkinson's Disease
    Susan R. Goulding · 2021
12. Elucidating regulators and biomarkers of synaptic stability during neurodegeneration
    Maica Llavero Hurtado · 2018
13. Review of brain functional connectivity emotional analysis in Parkinson’s disease patients
    M. Mohammad Fauzi, Abu Hassan Abdullah, Vikneswaran Vijean, M. Murugappan, Muhammad Aizat Abu Bakar · 2018 · AIP conference proceedings
14. [ID 51344] SOBRECARGA DE CUIDADORES DE INDIVÍDUOS COM A DOENÇA DE PARKINSON: ATIVIDADE FÍSICA, QUALIDADE DE VIDA E SINTOMAS DEPRESSIVOS
    Nataly Souza Severo, Jéssica Moratelli, Zênite Machado, Adriana Coutinho de Azevedo Guimarães · 2020 · Revista Brasileira de Ciências da Saúde
15. Oxidative stress-induced parkin misfolding, aggregation, and toxicity
    Martin L. Duennwald, Gary S. Shaw, Mohammad Ali Esmaeili, Jane R. Rylett, Susanne Schmid, Alexander S McCarton, Asit Rai, Cleusa De Oliveira, Sonja E. Di Gregorio, Taylor V. Roebotham · 2020
16. Comorbidities of depression and Parkinson’s disease
    Tanvi Dayanand Pingale, Girdhari Lal Gupta · 2021 · Elsevier eBooks
17. Cellular bioenergetics in human iPSC–derived glutamatergic neurons in health and disease
    Blanca I. Aldana, Claudia Salcedo, Kristine Freude, Helle S. Waagepetersen · 2021 · Elsevier eBooks
18. Estudo da neuropatia periférica em pacientes com doença de Parkinson: Revisão de literatura
    Antonia Viana, João Santos Pereira, Robson Teixeira Vital · 2021 · Research Society and Development
19. Alfa-sinukleina biomarkatzaile gisa Parkinson gaixotasunaren diagnostikoan
    Ane Murueta‐Goyena, Maider Zubelzu, Teresa Morera‐Herreras · 2021 · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria
20. Potentials of autophagy enhancing natural products in the treatment of Parkinson disease
    Taiwo Grace Olubodun-Obadun, Ismail Ogunbayode Ishola, Olufunmilayo Olaide Adeyemi · 2021 · Drug Metabolism and Personalized Therapy
21. Lesions in the Hippocampus and Substantia Nigra of Wistar Rats’ Brains Induced by Organophosphate Insecticide
    Ebtihajah Zaalan, Mahmoud Qassem, Muhammad Bilal · 2021 · Scientific Journal of King Faisal University Basic and Applied Sciences
22. Perspective Chapter: NMDA Treatments for CNS Disorders
    Chih-Hung Lin, Po‐Chang Shih, Guochuan Emil Tsai · 2021 · IntechOpen eBooks
23. Neural Substrates for the Association Between Cigarette Smoking and Parkinson's Disease
    Chao Wang, Cheng Zhou, Tao Guo, Peiyu Huang, Xiaojun Xu, Minming Zhang · 2021 · Research Square
24. Therapeutic and Diagnostic Agents for Parkinson's Disease
    Ola M. Ghoneim, Raymond G. Booth · 2021 · Burger's Medicinal Chemistry and Drug Discovery
25. Primenenie gistohimicheskih krasitelej dlya fluorescentnogo vyyavleniya amiloidnyh skoplenij v tkanyah cheloveka
    В. В. Гусельникова, Д. А. Суфиева, Д. Л. Цыба, Dmitriy E. Korzhevsky · 2021 · Вестник Российского государственного медицинского университета
26. Tracking Neurodegeneration: Advancement in Experimental Study Models
    Murugesan Arumugam, Sugin Lal Jabaris S · 2022 · Springer eBooks
27. Development of medical polymers for applications in neurological disorders
    Francisca Espinoza, Walther Ide, Natalia Saldivia, Diego Zelada · 2022 · Elsevier eBooks
28. Rheum turkestanicum Janisch Root Extract Mitigates 6-OHDA-Induced Neuronal Toxicity Against Human Neuroblastoma SH-SY5Y Cells
    Roghayeh Rashidi, Amir R. Afshari, Hamid Mollazadeh, Azar Hosseini · 2022 · Journal of Advances in Medical and Biomedical Research
29. Food consumption, anthropometry and body composition of patients diagnosed with Parkinson’s disease
    Gleyce Kelly de Araújo Bezerra, Marcella Campos Lima da Luz, Maria Goretti Pessôa de Araújo Burgos, Maria da Conceição Chaves de Lemos, John Weyk Cosme De Souza, Poliana Coelho Cabral · 2022 · Revista de Nutrição
30. Evaluating the Effect of Galvanic Vestibular Stimulation in Parkinson's disease via Microstate Resting State EEG Analysis
    Kosar Sanjar Arani, Alireza Kazemi, Maryam S. Mirian, Abdol‐Hossein Vahabie, Wyatt D. Verchere, Soojin Lee, Hamid Soltanian-zadeh A, Martin J. McKeown · 2022 · National and International Iranian Conference on Biomedical Engineering (ICBME)
31. ИСТОРИЯ ИЗУЧЕНИЯ БОЛЕЗНИ ПАРКИНСОНА
    Копылова Лилия Ивановна, А.А. Таппахов, Т.Я. Николаева · 2023 · Vestnik of North-Eastern Federal University Medical Sciences
32. Developing a Machine Learning-Based Multiple Disease Prediction System: A Comprehensive Analysis of Risk Factors and Disease Interactions
    Emad Naushad, Bhavishya Raj, Arpit Nirvan, Vrinda Sachdeva · 2023 · International Journal of Advanced Research in Science Communication and Technology
33. Multi-functional Ligands and Molecular Hybridization: Conceptual Aspects and Application in the Innovative Design of Drug Candidate Prototypes for Neurodegenerative Diseases
    Matheus de Freitas Silva, Flávia Pereira Dias Viegas, Vanessa Silva Gontijo, Cindy Juliet Cristancho Ortiz, Graziella dos Reis Rosa Franco, Januário Tomás Ernesto, Caio Miranda Damásio, Gabriel Pinto da Silva Fonseca, Isabela Marie Fernandes Silva, Larissa Emika Massuda et al. · 2023 · Frontiers in clinical drug research. CNS and neurological disorders
34. In Parkinson's Disease, the Active Ingredients of Chinese Medicine in Regulating Inflammation in Glial Cells Based on the NF-κB Pathway
    Jing-jing Song, Yang Zhao, Xiaoqian Shan, Yongyin Luo, Nan Hao, Lan Zhao · 2023 · SSRN Electronic Journal
35. Роль Т-клеточных субпопуляций в патогенезе и терапии болезни Паркинсона (обзор литературы)
    Galina V. Idova, Альперина Елизавета Лазаревна, Svetlana Ya. Zhanaeva · 2023 · Сибирский вестник психиатрии и наркологии
36. Association between metabolic syndrome and progression in Parkinson's disease
    Saloni Sharma, David Oakes, Shirley W. Eberly, Carlos Singer, Jillian Lowell, Tanya Simuni · 2023 · Clinical Epidemiology and Global Health
37. Perception of cognitive change by individuals with Parkinson’s disease or essential tremor seeking deep brain stimulation: Utility of the cognitive change index
    Katie Rodriguez, Rachel N. Schade, Francesca V. Lopez, Lauren E. Kenney, Adrianna M. Ratajska, Joshua Gertler, Dawn Bowers · 2023 · Journal of the International Neuropsychological Society
38. Estudo prospectivo aleatorizado para avaliar a eficácia e a segurança da estimulação magnética da medula espinhal na dor nociceptiva em pacientes com doença de Parkinson
    Jorge Dornellys da Silva Lapa · 2023
39. Design of a Predictor Model for Feature Selection using Machine Learning Approaches
    P. Pradeep · 2024 · Journal of Electrical Systems
40. Experimental Animal Models in Neurological Diseases
    Neslihan Şirin, Şerif Demír · 2024 · Düzce Tıp Fakültesi Dergisi
41. Asociación Mexicana de Neuropsicología. 25 años de práctica clínica e investigación
    Adela Hernández-Galván, Bernarda Téllez-Alanís, Miguel Rodríguez · 2023 · Universidad Autónoma del Estado de Morelos eBooks
42. DIAGNOSIS OF PARKINSON'S DISEASE BY BIOMEDICAL IMAGING METHODS ON THE EXAMPLE OF A CLINICAL CASE
    V. V. Ryazanov, V. Kutsenko, Роман Анатольевич Постаногов, Pavel Vasilievich Seliverstov, Марат Риатович Гафиатулин · 2023 · Vrach
43. Burden of non-motor symptoms in Parkinson’s disease and atypical parkinsonism syndromes: A single-center cross-sectional comparison study
    Narendra Barad, Dnyaneshwar Asole, Mahendra Thakre, Charulata Savant Sankhla · 2024 · Annals of Movement Disorders
44. Smart Monitoring of Parkinson's Disease With Cloud-IoT Technologies
    B V Baiju, Pragnya Suresh, V. Ceronmani Sharmila, M. Deepa, D. Kirubha, Feslin Anish Mon · 2024 · Advances in healthcare information systems and administration book series
45. Hsp60 and nervous system development and diseases
    Federica Scalia, Francesco Cappello, Everly Conway de Macario, Alberto J.L. Macario · 2024 · Elsevier eBooks
46. Calcium Signaling and Neurocognition
    Hardik Joshi · 2024 · Springer eBooks
47. Multi-Source Unsupervised Domain Adaptation for Neuron Membrane Segmentation via Feature Enhancement
    Yuxiang An, Dongnan Liu, Weidong Cai · 2024 · International Conference on Digital Image Computing: Techniques and Applications (DICTA)
48. Morphological Analysis of MR in PD Whole Brain Structure and Resting State fMR Study
    继辉 张 · 2025 · Advances in Clinical Medicine
49. The Effects of Amplitude-Based Training on Mobility, Functional Leg Strength, and Balance Confidence in Persons with Parkinson’s Disease with and Without Deep Brain Stimulation: A Case Series
    Rosemary Lackey Babcock, Abigail Anderson, Laurie Neely, Christina Speranza, Caitlyn Wilkerson, Jennifer Tolle, Kathleen Salik, Rolando Lazaro, Morris Casano Beato · 2025 · Advances in Geriatric Medicine and Research
50. Role of 6-Fluoro-18F-l-3,4-DOPA MR-PET in Clinical Workup in Movement Disorders Cases: An Exploratory Study in a Tertiary Care Neuropsychiatric Setup
    Keerti Sitani, Sandhya Mangalore, Manoj Kumar, Pardeep Kumar, Pawan Bairwa, Venkatesh Murthy Konappa Agrahara Shama · 2025 · Indian Journal of Nuclear Medicine
51. Phytochemicals against the 6-hydroxydopamine-induced Parkinson’s disease in rodents: A systematic review
    Sara Abidar, Mohamed Nhiri, Lucian Hriţcu · 2025 · Next research.
52. GDNF Gene Therapy for Parkinson’s Disease
    Adrian P. Kells, Amber D. Van Laar, Krystof S. Bankiewicz · 2025 · Springer eBooks
53. Desfechos funcionais e qualidade de vida em pacientes com Doença de Parkinson submetidos a um protocolo fisioterapêutico baseado em problemas
    Eliel Freitas da Cunha, Shirley Lima Campos, Marcelo Renato Guerino, Maria das Graças Paiva, Mateus Augusto Felix de Melo, Elisa Granha Lira, Diana de Andrade Silva, Maria das Graças Rodrigues de Araújo · 2025 · Caderno Pedagógico
54. Aging and Neurodegeneration
    Gaurav Gupta, Raihan Siddique, Riya Thapa, Asif Ahmad Bhat, Md Sadique Hussain, Thakur Gurjeet Singh, Sachin Kumar Singh, Saurabh Gupta, Pran Kishore Deb, Moayad Al Shahwan · 2025 · Springer eBooks
55. CD11b Activation Reduces Myeloid Brain Infiltration and Mitigates Synucleinopathy in a Model of Parkinson’s Disease
    Ameera M. Shaw, Viviana Jiménez, Billy Nguyen, Jayda B. Duvernay, Solji G. Choi, Mike Cameron, Bryan A. Killinger, Vineet Gupta · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
56. Clinical value of serum miR-451 in early diagnosis of multiple system atrophy from parkinson’s disease and outcomes prediction
    Tingyan Shi, Zhongzheng Jia · 2025 · Acta Neurologica Belgica
57. Calcium Signaling and Neurocognition
    Hardik Joshi · 2025 · Springer eBooks
58. In silico Analysis and Antioxidant Activity of Flavonoids from Tinospora cordifolia Targeting α-Synuclein of Parkinson’s Disease
    Jayashree Pandurangan, Hanishka Pothiraj, Meenambiga Setti Sudharsan · 2025 · Asian Journal of Chemistry
59. Patterns in Drawings of Parkinson’s Disease Patients Versus Healthy People Utilizing Markerless Object Tracking with Machine Learning
    José Renato Munári Nardo, Caio Tonus Ribeiro, Camille Marques Alves, Daniel Hilário da Silva, Eduardo Moura Neto, Luanne Cardoso Mendes, Adriano Alves Pereira, Adriano de Oliveira Andrade · 2025 · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany
60. CNS-11g reduces α-synuclein pathology and restores motor function in a Parkinson’s model
    Sally Ann Frautschy, Kapil Manglani, Xiaohong Zuo, Cansheng Zhu, Mychica R. Jones, Alex Bombino, Hope Pan, Ke Hou, J.M. Kwon, Bruce Teter et al. · 2025 · Research Square
61. MOLECULAR ANALYSIS OF MITOCHONDRIAL COMPLEX I IN THE RESPONSIVENESS TO LEVODOPA IN PARKINSON’S DISEASE
    Ana Gabrielle Bispo, Felipe Gouvêa de Souza, Matheus Caetano Epifane-de-Assunção, Camille Sena-dos-Santos, Gustavo Barra Matos, Dafne Dalledone Moura, Gracivane Lopes Eufraseo, Caio Santos Silva, Gilderlânio Santana de Araújo, Ândrea Ribeiro‐dos‐Santos et al. · 2025 · medRxiv
62. Axon-specific mRNA translation shapes dopaminergic circuit development
    Charles Gora, Béatrice Frenette, Pauline A. Gelon, Chantelle F. Sephton, Samer M. I. Hussein, Emmanouil Metzakopian, Martin Lévesque · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
63. Harnessing herbal remedies for alleviating Parkinson’s symptoms
    Sachchida Nand, Payal Singh, Falguni Goel · 2025 · Elsevier eBooks
64. Additional file 12 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Yiyuan Liu, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare
65. Detection of Neurological Disorders Using Advanced AI Techniques
    KR Anudeep Laxmikanth, T. Kishore Kumar · 2024 · IEEE Region 10 Conference (TENCON)
66. Additional file 3 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Liu, Yiyuan, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare
67. Additional file 15 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Liu, Yiyuan, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare
68. Additional file 8 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Liu, Yiyuan, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare
69. Additional file 11 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Liu, Yiyuan, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare
70. Additional file 7 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Liu, Yiyuan, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare
71. Additional file 10 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Liu, Yiyuan, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare
72. Additional file 9 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Liu, Yiyuan, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare
73. Additional file 1 of Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
    Hiroaki Sekiya, Asato Tsuji, Hashimoto, Yuki, Mariko Takata, Shunsuke Koga, Katsuya Nishida, Naonobu Futamura, Michi Kawamoto, Nobuo Kohara, Dennis W. Dickson et al. · 2022 · Figshare
74. Additional file 4 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Liu, Yiyuan, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare
75. Additional file 14 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Liu, Yiyuan, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare
76. Additional file 1 of Study of the gut microbiome in Egyptian patients with Parkinson’s Disease
    Mohammad Mehanna, Suzan AbuRaya, Shwikar Mahmoud Ahmed, Ghada Abdel Hady Ossman Ashmawy, Ibrahim, Ahmed, Essameldin AbdelKhaliq · 2024 · Figshare
77. Additional file 1 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Liu, Yiyuan, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare
78. Additional file 6 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Liu, Yiyuan, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare
79. Additional file 1 of Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease
    Hall, Sara, Christina Doriana Orru, Serrano, Geidy E., Galasko, Douglas, Andrew G. Hughson, Bradley R. Groveman, Charles H. Adler, Beach, Thomas G., Caughey, Byron, Oskar Hansson · 2022 · Figshare
80. Additional file 5 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Liu, Yiyuan, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare
81. Additional file 2 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Liu, Yiyuan, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare
82. Additional file 13 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
    Bowles, Kathryn R., Derian A. Pugh, Liu, Yiyuan, Tulsi Patel, Alan Edward Renton, Sara Bandrés‐Ciga, Ziv Gan‐Or, Peter Heutink, Siitonen, Ari, Sarah E. Bertelsen et al. · 2022 · Figshare
83. Occupational Pesticide Exposure and Regional Brain Volume Differences in UK BioBank
    Shane Johnson, Adam Kehl, Jonathen Ahern, Mary E. T. Boyle, Robert J. Loughnan · 2025 · medRxiv
84. Quantitative brain regional relaxometry metrics for early diagnosis of Parkinson's disease
    Miao Chen, PuYeh Wu, Wenjia Wang, YiFei Zhang, Rui Zhang, Jinpeng Qi, Zhibo Liang, Lihong Gao, Gang Zhang · 2025 · Psychiatry Research Neuroimaging
85. α-Synuclein Real-Time Quaking-Induced Conversion Assay as a Biomarker for Parkinson’s Disease: Clinical Implications and Perspectives
    Je Kook Yu, Yun Kyung Lee, Dong A Yea, Young Eun Kim · 2026 · Journal of Clinical Neurology
86. ApoE in Synucleinopathies
    José Wagner Leonel Tavares-Júnior, Andre Borges Ferreira Gomes, Pedro Braga‐Neto · 2025 · Springer eBooks
87. Cerebral activation following dynamic cycling in individuals with and without Parkinson's disease: an fNIRS investigation
    Brittany E. Smith, Lara M. Shigo, Julia Jones Huyck, Angela L. Ridgel · 2026 · Frontiers in Human Neuroscience
88. Therapeutic Potential of Macroalgae- and Microalgae-Derived Bioactive Compounds in Parkinson’s Disease
    Jia Yee Lee, Luis Wei Cheng Lim, Chiew-Yen Wong, Rhun Yian Koh, Chooi Ling Lim, Yih-Yih Kok, Soi Moi Chye · 2026 · CNS & Neurological Disorders - Drug Targets
89. The brainstem in neurodegenerative diseases
    Lea T. Grinberg · 2026 · Handbook of clinical neurology
90. Evaluation of an In Situ Polymerizing Hydrogel Scaffold as a Brain Delivery System for Parkinson’s Disease therapeutics
    Francesco Gubinelli · 2019 · theses.fr (ABES)
91. Étude génétique et corrélation génotype-phénotype de la maladie de Parkinson dans la population tunisienne
    Sawssan Ben Romdhan · 2019
92. DNAJC6 Parkinson’s disease: Endolysosomal dysfunction and emerging roles for oligodendrocytes
    Angel G Allen, Sarah J. Stednitz, Michael T. Lardelli, Karissa Barthelson · 2026 · npj Parkinson s Disease
93. Towards the integration of body-worn sensors in the management of Parkinson’s disease : perspectives on new paradigms of follow-up
    Clara Virbel-Fleischman · 2021 · theses.fr (ABES)
94. Up-regulation of tRNA-derived miR-1274b in tears of Parkinson's disease patients
    Erika Salvi, Ilaria Vannetiello, Federico Angelo Cazzaniga, Arianna Ciullini, Antonia Franziska Demleitner, Nico Golfrè Andreasi, Simone Tomè, Antonio Emanuele Elia, Valentina Leta, Paul Lingor et al. · 2026 · Parkinsonism & Related Disorders
95. Brain on a chip : to reconstruct multi-nodal neuronal networks in vitro for neurodegenerative disease modelling
    Teng Pan · 2022 · theses.fr (ABES)
96. Study of the interactions between the nervous system and the gut in Parkinson’s disease using Drosophila
    Xiaojing Yue · 2022
97. Impact de la personnalité sur la qualité de vie dans la maladie de Parkinson au stade des fluctuations motrices
    Mathilde Boussac · 2021
98. Nigral Neuromelanin and Iron Content characterizing Parkinson's Disease and REM Sleep Behavior Disorder : A Multimodal MRI Study using Deep Learning
    Rahul Gaurav · 2021
99. Apport de l'IRM multimodale pour le diagnostic différentiel des syndromes parkinsoniens
    Lydia Chougar · 2022
100. Naftidrofuryl Exerts Neuroprotective Effects in a Rotenone-Induced Rat Model of Parkinson’s Disease Through Modulation of PINK1/Parkin and ER Stress Pathways
     Saad Misfer Alqahtani, Ehab A. M. El‐Shoura, Lobna A. Abdelzaher, Souty M.Z. Sharkawi, Ahmed M. Atwa, Maha Hosni Morsi, ‏Hebatallah M. Saad, Basel A. Abdel‐Wahab · 2026 · NeuroMolecular Medicine